ACUIX
Price
$37.55
Change
-$0.39 (-1.03%)
Updated
Sep 6 closing price
VVIAX
Price
$65.30
Change
-$0.84 (-1.27%)
Updated
Sep 6 closing price
Ad is loading...

ACUIX vs VVIAX

Header iconACUIX vs VVIAX Comparison
Open Charts ACUIX vs VVIAXBanner chart's image
Columbia Dividend Opportunity C
Price$37.55
Change-$0.39 (-1.03%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$65.30
Change-$0.84 (-1.27%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
ACUIX vs VVIAX Comparison Chart
Loading...
VS
ACUIX vs. VVIAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACUIX is a StrongBuy and VVIAX is a Buy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 183B vs. ACUIX (2.15B). VVIAX pays higher dividends than ACUIX: VVIAX (2.36) vs ACUIX (2.02). ACUIX was incepted earlier than VVIAX: ACUIX (24 years) vs VVIAX (24 years). ACUIX is a more actively managed with annual turnover of: 52.00 vs. VVIAX (10.00). ACUIX has a lower initial minimum investment than VVIAX: ACUIX (2000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 19.30 vs. ACUIX (17.49). VVIAX return over 5 years is better than : 53.51 vs. ACUIX (15.12).
ACUIXVVIAXACUIX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years24 years-
Gain YTD12.89413.50695%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets2.15B183B1%
Annual Yield % from dividends2.022.3686%
Returns for 1 year17.4919.3091%
Returns for 3 years3.4819.6818%
Returns for 5 years15.1253.5128%
Returns for 10 years2.56107.572%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDYN14.080.47
+3.45%
Grid Dynamics Holdings
USEG0.910.01
+1.00%
US Energy Corp
BCE35.950.07
+0.20%
BCE
LNKB6.15N/A
N/A
LINKBANCORP
CRNX50.98-1.82
-3.45%
Crinetics Pharmaceuticals